Trine L. J.
- Country
- Denmark
- Department
- Department of Oncology
Research Overview
- Evaluation of XmAb541 in Patients with Advanced Solid Tumors: A Phase I Clinical Trial
- Phase III Study of AZD5335 Versus Mirvetuximab Soravtansine or Investigator's Choice Chemotherapy in Patients with FRα-High or FRα-Low Platinum-Resistant Epithelial Ovarian Cancer
- Phase 3 Randomized Study of Dostarlimab Plus Carboplatin-Paclitaxel Versus Placebo in Recurrent or Primary Advanced Endometrial Cancer
Data & Insights
Has run more than one trial at 66 of 210 partner sites.
Specializations
Gynecologic Oncology
The investigator specializes in treating advanced gynecologic malignancies, with particular emphasis on recurrent epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer.
- Ovarian Cancer Treatment
- Peritoneal Malignancies
- Fallopian Tube Neoplasms
Their expertise extends to platinum-based therapeutic approaches for gynecologic cancers.
Solid Tumor Oncology
The investigator focuses on diverse solid tumor treatments, including hepatocellular carcinoma, colorectal cancer, and various other solid malignancies.
- Liver Cancer Management
- Colorectal Oncology
- Novel Combination Therapies
Their work encompasses innovative therapeutic combinations for multiple solid tumor types.
Endometrial Cancer
The investigator has significant involvement in treating advanced endometrial cancer, with expertise in both primary and recurrent disease states.
- Advanced Stage Treatment
- Recurrent Disease Management
- Immunotherapy Applications
Their focus includes treatment strategies for both early and late-stage endometrial cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.